Etv6em1Ccpo
Endonuclease-mediated Allele Detail
|
|
| Symbol: |
Etv6em1Ccpo |
| Name: |
ets variant 6; endonuclease-mediated mutation 1, Christopher C Porter |
| MGI ID: |
MGI:7572876 |
| Synonyms: |
Etv6mt |
| Gene: |
Etv6 Location: Chr6:134012663-134247121 bp, + strand Genetic Position: Chr6, 64.58 cM, cytoband G2
|
| Alliance: |
Etv6em1Ccpo page
|
|
| Strain of Origin: |
Not Applicable
|
|
| Allele Type: |
|
Endonuclease-mediated (Dominant negative, Humanized sequence) |
| Mutation: |
|
Single point mutation
|
| |
|
Mutation details: Proline codon 216 (CCA) in exon 5 was changed to leucine (CTA) (p.P216L) using an sgRNA and an ssODN template with CRISPR/Cas9 technology. The mutation is the equivalent of the human p.P214L (c.641C>T) mutation associated with the autosomal dominant syndrome of thrombocytopenia and leukemia predisposition.
(J:342734)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Etv6 Mutation: |
144 strains or lines available
|
|
| Original: |
J:342734 Zhou C, et al., Germline ETV6 mutation promotes inflammation and disrupts lymphoid development of early hematopoietic progenitors. Exp Hematol. 2022 Jul 6; |
| All: |
1 reference(s) |
|